Enliven Therapeutics
ELVN
ELVN
38 hedge funds and large institutions have $61.8M invested in Enliven Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $86.3M → $61.8M (-$24.5M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $60K
Holders
38
Holding in Top 10
–
Calls
–
Puts
$60K
Top Buyers
| 1 | +$8.66M | |
| 2 | +$4.33M | |
| 3 | +$4.31M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$1.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.52M |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.74M | |
| 3 | -$1.53M | |
| 4 |
Morgan Stanley
New York
|
-$719K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$296K |